Streetbeat News

Price Targets

SWK

JP Morgan analyst Michael Rehaut has downgraded Stanley Black & Decker (SWK) from Neutral to Underweight and set a price target of $89.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:57 am

TRIP

BTIG analyst Jake Fuller has upgraded TripAdvisor (NASDAQ:TRIP) from Neutral to Buy and set a price target of $25. This upgrade suggests a positive outlook for TripAdvisor's stock.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:55 am

WHR

JP Morgan analyst Michael Rehaut has maintained a Neutral rating on Whirlpool (NYSE:WHR) but increased the price target from $104 to $120.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:53 am

MPC

Wells Fargo analyst Roger Read has upgraded Marathon Petroleum (NYSE:MPC) from Equal-Weight to Overweight and set a price target of $169.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:51 am

IBP

JP Morgan analyst Michael Rehaut has upgraded Installed Building Products (IBP) from Neutral to Overweight and increased the price target from $165 to $199.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:46 am

BLD

JP Morgan analyst Michael Rehaut has upgraded TopBuild (NYSE:BLD) from Neutral to Overweight and increased the price target from $312 to $387, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:44 am

TREX

JP Morgan analyst Michael Rehaut has upgraded Trex Co (NYSE:TREX) from Underweight to Neutral and increased the price target from $62 to $79.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:42 am

BECN

JP Morgan analyst Michael Rehaut has upgraded Beacon Roofing Supply (BECN) from Neutral to Overweight and increased the price target from $86 to $103. This upgrade reflects a positive outlook on BECN's stock, suggesting potential for growth beyond the current market price.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:41 am

PFE

Barclays analyst Carter Gould has maintained an Equal-Weight rating on Pfizer (NYSE:PFE) but has reduced the price target from $34 to $28.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:41 am

CSTL

Guggenheim analyst Subbu Nambi has initiated coverage on Castle Biosciences (NASDAQ:CSTL) with a Buy rating and set a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:38 am